Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001306392 | SCV001495764 | likely benign | not provided | 2022-11-15 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001306392 | SCV002541415 | uncertain significance | not provided | 2021-12-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493607 | SCV002799792 | uncertain significance | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001306392 | SCV003821399 | uncertain significance | not provided | 2023-08-03 | criteria provided, single submitter | clinical testing |